The effect of sarpogrelate compared to aspirin in high- or very-high-risk diabetes for primary prevention

The effect of sarpogrelate compared to aspirin in high- or very-high-risk diabetes for primary prevention

Abstract The benefit of aspirin in primary prevention for atherosclerotic cardiovascular diseases (ASCVD) is questionable due to bleeding complications. We analyzed the Korean National Health Insurance data to compare the efficacy and overall bleeding of sarpogrelate, an antiplatelet agent with lowe...

Full description

Saved in:
Bibliographic Details
Main Authors: Soo Hyun Kang, Kilyoon Pack, Jung Ho Kim, Youngwoo Jang
Format: Article
Language:English
Published: Nature Portfolio 2025-01-01
Series:Scientific Reports
Subjects:
Aspirin
Diabetes
Bleeding
Primary prevention
Sarpogrelate, antiplatelet therapy
Online Access:https://doi.org/10.1038/s41598-025-87868-x
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items